These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

332 related items for PubMed ID: 3635565

  • 1. Relationship between the component and regulatory proteins of the classical pathway C3 convertase.
    Welch TR, Forristal J, Beischel L.
    J Lab Clin Med; 1986 Jun; 107(6):529-33. PubMed ID: 3635565
    [Abstract] [Full Text] [Related]

  • 2. Relative importance of C4 binding protein in the modulation of the classical pathway C3 convertase in patients with systemic lupus erythematosus.
    Daha MR, Hazevoet HM, Hermans J, van Es LA, Cats A.
    Clin Exp Immunol; 1983 Oct; 54(1):248-52. PubMed ID: 6604610
    [Abstract] [Full Text] [Related]

  • 3. A model system for the study of the assembly and regulation of human complement C3 convertase (classical pathway).
    Thielens NM, Colomb MG.
    Eur J Immunol; 1986 Jun; 16(6):617-22. PubMed ID: 3487454
    [Abstract] [Full Text] [Related]

  • 4. [Formation of classical C3 convertase during the alternative pathway of human complement activation].
    Kozlov LV, Shibanova ED, Zinchenko AA.
    Biokhimiia; 1987 Apr; 52(4):660-6. PubMed ID: 3647798
    [Abstract] [Full Text] [Related]

  • 5. Protection of the classical and alternative complement pathway C3 convertases, stabilized by nephritic factors, from decay by the human C3b receptor.
    Fischer E, Kazatchkine MD, Mecarelli-Halbwachs L.
    Eur J Immunol; 1984 Dec; 14(12):1111-4. PubMed ID: 6240408
    [Abstract] [Full Text] [Related]

  • 6. Mechanism of activation of the classical pathway of complement by monoclonal IgE (DES). Restricted regulation of C4b by C4b-binding protein.
    Saint-Remy JM.
    Eur J Immunol; 1984 Mar; 14(3):254-9. PubMed ID: 6608450
    [Abstract] [Full Text] [Related]

  • 7. Surface modulation of classical pathway activation: C2 and C3 convertase formation and regulation on sheep, guinea pig, and human erythrocytes.
    Brown EJ, Ramsey J, Hammer CH, Frank MM.
    J Immunol; 1983 Jul; 131(1):403-8. PubMed ID: 6602833
    [Abstract] [Full Text] [Related]

  • 8. Pathways of complement activation in membranoproliferative glomerulonephritis and allograft rejection.
    Fearon DT, Daha MR, Strom TB, Weiler JM, Carpenter CB, Austen KF.
    Transplant Proc; 1977 Mar; 9(1):729-39. PubMed ID: 325806
    [Abstract] [Full Text] [Related]

  • 9. Regulation and deregulation of the fluid-phase classical pathway C3 convertase.
    Gigli I, Sorvillo J, Halbwachs-Mecarelli L.
    J Immunol; 1985 Jul; 135(1):440-4. PubMed ID: 3158705
    [Abstract] [Full Text] [Related]

  • 10. Relative resistance of the F-42-stabilized classical pathway C3 convertase to inactivation by C4-binding protein.
    Daha MR, van Es LA.
    J Immunol; 1980 Nov; 125(5):2051-4. PubMed ID: 6903579
    [Abstract] [Full Text] [Related]

  • 11. Regulation of immune complex-mediated complement activation by autoantibodies (F-42) isolated from sera of patients with systemic lupus erythematosus.
    Daha MR, Hazevoet HM, Vanes LA.
    Clin Exp Immunol; 1983 Sep; 53(3):541-6. PubMed ID: 6604604
    [Abstract] [Full Text] [Related]

  • 12. [Hereditary complement deficiencies].
    Fischer E.
    Hautarzt; 1982 Feb; 33(2):65-72. PubMed ID: 6281215
    [Abstract] [Full Text] [Related]

  • 13. Complement component C2, inhibiting a latent serine protease in the classical pathway of complement activation.
    Halili MA, Ruiz-Gómez G, Le GT, Abbenante G, Fairlie DP.
    Biochemistry; 2009 Sep 08; 48(35):8466-72. PubMed ID: 19642650
    [Abstract] [Full Text] [Related]

  • 14. Activation of the classical complement pathway by nephritic factor bound to the alternative pathway C3/C5 convertase.
    Sobel AT, Cooper NR, Schreiber RD.
    J Immunol; 1979 Jan 08; 122(1):34-8. PubMed ID: 762421
    [Abstract] [Full Text] [Related]

  • 15. A complement-resistant HeLa cell line (T638) is blocked at the step of C3 deposition.
    Santi P, Joiner KA, Hammer CH, Frank MM, Tosi R.
    J Immunol; 1987 May 15; 138(10):3385-91. PubMed ID: 2952716
    [Abstract] [Full Text] [Related]

  • 16. Modulation of complement by autoimmune antibodies isolated from sera of patients with membranoproliferative glomerulonephritis and systemic lupus erythematosus.
    Daha MR, Van Es LA.
    Neth J Med; 1982 May 15; 25(7):202-7. PubMed ID: 6924073
    [No Abstract] [Full Text] [Related]

  • 17. Effect of decay-accelerating factor on the assembly of the classical and alternative pathway C3 convertases in the presence of C4 or C3 nephritic factor.
    Ito S, Tamura N, Fujita T.
    Immunology; 1989 Dec 15; 68(4):449-52. PubMed ID: 2481642
    [Abstract] [Full Text] [Related]

  • 18. Modulation of the classical pathway C3 convertase by plasma proteins C4 binding protein and C3b inactivator.
    Gigli I, Fujita T, Nussenzweig V.
    Proc Natl Acad Sci U S A; 1979 Dec 15; 76(12):6596-600. PubMed ID: 293746
    [Abstract] [Full Text] [Related]

  • 19. [Lupus and protein deficiencies of the classical complement pathway].
    Weiss L, Maillet F, Kazatchkine M.
    Rev Prat; 1990 Sep 21; 40(21):1937-40. PubMed ID: 2237185
    [Abstract] [Full Text] [Related]

  • 20. Isolation of a human erythrocyte membrane glycoprotein with decay-accelerating activity for C3 convertases of the complement system.
    Nicholson-Weller A, Burge J, Fearon DT, Weller PF, Austen KF.
    J Immunol; 1982 Jul 21; 129(1):184-9. PubMed ID: 6211481
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.